Viral Delivery of GDNF Promotes Functional Integration of Human Stem Cell Grafts in Parkinson’s Disease-Reference-Cited by-同舟云学术

Viral Delivery of GDNF Promotes Functional Integration of Human Stem Cell Grafts in Parkinson’s Disease

Published:2020-04 Issue:4 Volume:26 Page:511-526.e5
ISSN:1934-5909
Container-title:Cell Stem Cell
language:en
Short-container-title:Cell Stem Cell

Author:

Gantner Carlos W.^ORCID,de Luzy Isabelle R.,Kauhausen Jessica A.,Moriarty Niamh,Niclis Jonathan C.,Bye Christopher R.,Penna Vanessa,Hunt Cameron P.J.,Ermine Charlotte M.,Pouton Colin W.,Kirik Deniz,Thompson Lachlan H.,Parish Clare L.

Funder

Vetenskapsrådet

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Cell Biology,Genetics,Molecular Medicine

Reference59 articles.

1. Nonsulfated cholecystokinins in cerebral neurons;Agersnap;Neuropeptides,2016

2. Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor;Ahn;Brain Res. Bull.,2005

3. Inducible Expression of GDNF in Transplanted iPSC-Derived Neural Progenitor Cells;Akhtar;Stem Cell Reports,2018

4. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson’s disease;Barker;Lancet Neurol.,2013

5. Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates;Behrstock;Gene Ther.,2006

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of NRG1-VII: the myeloid-derived class of NRG1;BMC Genomics;2024-08-29

2. Astrocytic GDNF ameliorates anesthesia and surgery-induced cognitive impairment by promoting hippocampal synaptic plasticity in aged mice;Neurochemistry International;2024-07

3. In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline;Stem Cell Reports;2024-06

4. Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses;Cell Research;2024-05-22

5. Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models;Stem Cell Research & Therapy;2024-05-12